Taj Worldwide | Taj Group | Media | Career | FAQs | Feedback | Contact us
 
Taj Logo

Carmustine 100mg Injection | Generics | Oncology Product Taj Oncology Group India Carmustine 100mg Injection manufacturer in India

go green Taj
 
Quality Medicines Api Generic Manufacturing For Doctors Brands Newsroom
 

pharma graph

 
  HOME >> Media  > Carmustine
Carmustine 100mg Injection | Generics | Oncology Product Taj Oncology Group India Carmustine 100mg Injection manufacturer in India

 

 


 

bomaby-high-court-denies-promoters-of-mumbai-based-taj-pharmaceuticals-limited-anticipatory-bailCarmustine
100mg Injection

Carmustine for Injection. Each package includes a vial containing 100 mg carmustine and an ampule containing 3 mL sterile diluent.

Carmustine is available in 100-mg single dose vials of lyophilized material. Sterile diluent for constitution of Carmustine is co-packaged with the active drug product for use in constitution of the lyophile. The diluent is supplied in an ampule containing 3 mL of Dehydrated Alcohol Injection, USP.

STORAGE

Store in a refrigerator (2°-8°C, 36°-46°F).
Store diluent at controlled room temperature (15°-30°C, 59°-86°F) or in a refrigerator (2°-8°C, 36°-46°F).

Important Note

The lyophilized dosage formulation contains no preservatives and is not intended for use as a multiple dose vial.

Stability

The unopened vial of the dry drug must be stored in a refrigerator (2°-8°C, 36°-46°F). The diluent ampules may be stored at controlled room temperature (15°-30°C, 59°-86°F) or in a refrigerator (2°-8°C, 36°-46°F). The recommended storage of unopened Carmustine vials provides a stable product for up to 3 years. After reconstitution as recommended, Carmustine is stable for 24 hours under refrigeration (2°-8°C, 36°-46°F). Reconstituted vials should be examined for crystal formation prior to use. If crystals are observed, they may be redissolved by warming the vial to room temperature with agitation.

Vials reconstituted as directed and further diluted to a concentration of 0.2 mg/mL in 5% Dextrose Injection, USP, should be stored at room temperature, protected from light and utilized within 8 hours.

Glass containers were used for the stability data provided in this section. Only use glass containers for Carmustine administration.

Important Note

Carmustine has a low melting point (30.5°-32.0°C or 86.9°-89.6°F). Exposure of the drug to this temperature or above will cause the drug to liquefy and appear as an oil film on the vials. This is a sign of decomposition and vials should be discarded. If there is a question of adequate refrigeration upon receipt of this product, immediately inspect the vial in each individual carton. Hold the vial to a bright light for inspection. The Carmustine will appear as a very small amount of dry flakes or dry congealed mass. If this is evident, the Carmustine is suitable for use and should be refrigerated immediately.

Taj Pharmaceuticals Group is committed to provide with recent news and updates of our corporation on regular basis. Our corporate communications team is dedicated to comply with neutrality of the news and events in accordance with global media norms.

Our FDA and Drug Approval news is available (Click here)


FDA has approved LOBIGRAN eye drops (brimonidine tartrate/timolol maleate ophthalmic solution) to treat elevated intraocular pressure (IOP) in people with glaucoma or high blood pressure of the eye, manufacturer Taj Pharmaceuticals Ltd.

Taj Pharma announces USFDA tentative approval for Various generic Medicines

The premier health and medical news on the Internet


Taj Pharma offers accurate, readable and informative news reports every day.

Medical News :

For the Professional

Prostate cancer vaccine improves disease-free survival.
Procalcitonin may help guide antibiotic therapy for pneumonia.
Hormone therapy not linked to age-related macular degeneration.


Industry Briefing :

For the Industry

UK pharma body reinstates Abbott, further review of conduct within six months.
ICD market could take longer to rebound: analysts.
Lexapro patent win sends Forest shares surging.


Health E-line :

For the Consumer

"Precooling" before exercise helps beat the heat.
Diabetes linked to higher glaucoma risk for women.
Shingles pain eased with two-pronged therapy.

  For more Media details :


The Bombay High Court in Sudhir Singh and Another vs. State of Maharashtra and Another, has rejected the anticipatory bail applications of directors of Taj Pharmaceuticals, for the offence of cheating, forgery punishable under IPC, selling or providing goods and services with a false trademark punishable .Emcure had approached IDMA IPR committee seeking assistance to take action against Taj Pharma for selling counterfeit version of cancer and brain tumour drug Carmustine in global market thereby jeopardizing public health, informed Dr Gopakumar Nair, chairperson of IDMA IPR committee. Emcure ...

Bomaby High Court denies promoters of Mumbai-based Taj Pharmaceuticals Limited anticipatory bail

By
DIVYA RAJAGOPAL
, ET Bureau|
Updated: Dec 05, 2016, 01.43 AM IST
MUMBAI: The Bombay High Court has denied promoters of Mumbai-based Taj Pharmaceuticals Limited anticipatory bail following allegations by rival Emcure Pharmaceuticals that Taj Pharmaceuticals was selling spurious versions of anti-cancer injectable drug brand Bicnu (carmustine).

"Justice Nitin Sambre rejected the anticipatory bail petition on the grounds of bringing disrepute to Indian pharma industry," said Hitesh Jain of law firm ALMT, which is representing Emcure Pharma.

 
This rejection means the court paved the way for the arrest of the promoters of Taj Pharma, Sudhir and Priyanka Singh, for selling and exporting spurious drugs, Jain told ET.

Taj Pharma executives, however, said the company has not yet heard of any decision.

"As objection, people keep postponing the debate on the plea," said an executive, who did not wish to be identified. Pune-based Emcure Pharma had in March filed a trademark infringement case against Taj Pharma charging its
its brand Bicnu was counterfeited.

The issue was subsequently resolved as the court ordered Taj Pharma to remove the stock that it was selling.

However, Taj Pharma maintained in its defence that it was not selling the injections under the Bicnu brand and contended that its marketed injection was sold under its own brand name Carmuther, manufactured by Hyderabad-based Theodore Pharma.
 
The company said it possessed all required marketing rights for selling and exporting this injection. Theodore Pharma did not respond to ET’s queries on its arrangement to supply the drug to Taj Pharma.

 

HC Disposed 'Copycat Drug' Claims and all Accusations Dropped Between Emcure Pharmaceuticals and Taj Pharmaceuticals

MUMBAI, April 26,2016/PRNewswire/ -

All Allegations of 'Spurious Drugs' Disposed Between the two Pharma Companies as Sales of Licensed Bio-Similar Found 

After a heated few weeks at Taj Pharmaceuticals Ltd. and raised questions related to Counterfeit Carmustine 100mg Injections; all the allegations have been dropped by Emcure Pharmaceuticals for their brand misuses. The Hon'ble High Court, Justice Gautam Patel during hearing from both companies, guided the difference between generic and brands on medicines to the present counsels. After a considerable amount of evidence filed by both companies, it was concluded that, the counterfeit allegations were mislead by an Israeli firm Raz Pharmaceuticals to trigger Emcure for this suit; creating an immense concern to judiciary system and both parties involved in the Carmustine Injections business. However, after it was identified that in-fact Taj Pharmaceuticals supplies a generic version of the same drug through its licensed associate Therdose Pharma Pvt. Ltd, the confusion related to sales of 'spurious, illicit drugs' was cleared and no such claims stood relevant after Taj Pharmaceuticals' reply, and after licenses were presented for this matter. After the reply by Taj Pharma; it was observed that; both companies were engaged with supply of same active ingredient 'carmustine' in the injection; which is used in the treatment of patients diagnosed with cancer, lymphoma and tumors.

     (Photo: http://photos.prnewswire.com/prnh/20160426/10144860 )

Senior counsel Dinyar Madon represented Taj Pharma; he outlined issues related to US FDA failures of Emcure Pharmaceuticals in March 2016, as a possible motive behind claims. However, setting aside all contentions, both companies agreed to protect intellectual property in question, follow FDA norms and disposed-off the matter since public health has been at question and a great deal of controversy between both the companies are related to this matter; as the companies were dealing with the same injection with main active ingredient 'carmustine'. Hon'ble High Court Justice Gautam Patel has clearly said in the judgment "There has been in the past great deal of controversy between the Emcure and Taj Pharma. I cannot within the frame of a civil suit address the grievances."

Living up to the 'Make in India' initiative, India always remains the prime choice of access to life saving drugs at an affordable prices.

About Taj Pharma Group 

Taj Pharma Group is one of the leading generic pharmaceutical company in India. We hold top positions in different established markets and are building a strong presence in many emerging generics markets. Our products cover a vast array of therapeutic categories, and we offer an extensive range of dosage forms and delivery systems including oral solids, controlled-release, steriles, injectables, topicals, liquids, transdermals, semi-solids and high-potency products.

        Pharmaceuticals Products | Diseases | Generic Index | Taj Generic | API | Manufacturing                                Pharmacological Index | Generic Medicines | PDF Download | DOC Download
                                          Brochures Download | API Manufacturing |
Virtual Tour of Plants

 
   


Taj Pharma as a Health Care Provider

research lab
 
help in the bottle

 


 


 



 

Company Brochure

books icon  Vision and Strategy At Taj Pharmaceuticals our goal is to create innovative drugs and diagnostic tools for the medicine of tomorrow more...

Milestones icon Milestones Three internally developed programs targeting IND enabling studies more...

doctor iconFor Doctors We hope our website will help Doctors, Patients and the General Public a better understanding of disease and the many issues that surround it more...

products Quality iconQuality Test Equipment and Facilities The manufacturing facilities are based in Valsad (Gujarat) and Raigad (Raigarh, Maharashtra) and operated by more...

faqs iconFAQs Frequently Asked Questions (FAQ) This FAQ has been compiled for your convenience more..
And Many More Marketing Strategies

 

 

 



 

 

 

 

              
 Print page   Send by mail


 

 

 

 

 


 




 

Carmustine 100mg Injection. Carmustine for Injection. Each package includes a vial containing 100 mg carmustine and an ampule containing 3 mL sterile diluent. Carmustine is available in 100-mg single dose vials of lyophilized material. Sterile diluent for constitution of Carmustine is co-packaged with the active drug ...
Anti Cancer Medicines manufacturers, Anti Cancer Medicines suppliers, Anti Cancer Medicines traders, Anti Cancer Medicines producers, Anti Cancer , anticancer drugs india, anticancer drugs manufacturers, anticancer drugs exporters, manufacturer of anticancer products in india, suppliers of anti cancer drugs in india, anti cancer drugs, Manufacturing Facilities, Facility, manufacturing, production, sales, and exporting, Manufacturer of anti cancer drugs
Manufacturer of anti cancer drugs anti cancer medicines generic cancer drugs generic Generic Pharma generic manufacturer India Generics Supplier Generic Exporter Pharmaceuticals Generic Medicines Manufacturer Taj Oncology Taj Oncology manufacturer India gynace product anti-biotic skin products anti cold preparation anti bacterials gynec nutritional product Taj Oncology anti ulcer product Taj Oncology pharmaceutical generic pharmaceutical drug medical pharma healthcare pharma patents contract manufacturing Taj Oncology pharma generic pharma pharma pharmaceutical products pharmaceutical formulations generic medicine anti-biotics anti-fungal skin care Manufacturer gynaec nutritional anti-cold expectorant Pharmaceutical gmp formulations manufacturer Taj Oncology pharmaceutical medicine exporter from India pharma Taj Oncology medicine api generic medicine Taj Oncology herbal products health care products tablets capsules syrup & protein Taj Oncology powder nutraceuticals gynec products ortho products in India oncology products gastroenterology products orthopaedic products gynecology who gmp cGMP US FDA WHO UKMHRA Approved

Taj Pharma. MUMBAI: The Bombay High Court has denied promoters of Mumbai-based Taj Pharmaceuticals Limited anticipatory bail following allegations by rival Emcure Pharmaceuticals that Taj Pharmaceuticals was selling spurious versions of anti-cancer injectable drug brand Bicnu (carmustine).

 
   
 
 
   
   
   
  india flag
  The Taj Pharmaceuticals Limited (Taj Group) has operations in every major international market
  AFRICA
  ASIA PACIFIC
  EUROPE
  MIDDLE EAST
  THAILAND
  BANGLADESH
  NORTH AMERICA
  SOUTH AMERICA
  RUSSIA
  NEWZELAND
  UNITED KINGDOM
 

`  

 

 

 

 

 

 


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Manufacturer of anti cancer drugs anti cancer medicines generic cancer drugs generic Generic Pharma generic manufacturer India Generics Supplier Generic Exporter Pharmaceuticals Generic Medicines Manufacturer Taj Oncology Taj Oncology manufacturer India gynace product anti-biotic skin products anti cold preparation anti bacterials gynec nutritional product Taj Oncology anti ulcer product Taj Oncology pharmaceutical generic pharmaceutical drug medical pharma healthcare pharma patents contract manufacturing Taj Oncology pharma generic pharma pharma pharmaceutical products pharmaceutical formulations generic medicine anti-biotics anti-fungal skin care Manufacturer gynaec nutritional anti-cold expectorant Pharmaceutical gmp formulations manufacturer Taj Oncology pharmaceutical medicine exporter from India pharma Taj Oncology medicine api generic medicine Taj Oncology herbal products health care products tablets capsules syrup & protein Taj Oncology powder nutraceuticals gynec products ortho products in India oncology products gastroenterology products orthopaedic products gynecology who gmp cGMP US FDA WHO UKMHRA Approved

 

 

 

 

 
 www.tajpharma.com

   

Vacancies | C & F Agency | Distributor | Group Companies | History | Enquire Form | Countries | Pharma Technology
 Contact | Sitemap | User Terms and Conditions | Privacy and Cookie Statement